Interestingly, 35 out of 62 GBC expressed high levels of FABP1 in DI region, which include 28 out of 49 adenocarcinomas, 1 out of 5 neuroendocrine carcinomas, 2 out of 4 adenosquamous carcinomas, and all of 2 mixed adenoneuroendocrine carcinomas and 2 undifferentiated carcinomas. The gene discussed is FABP1; the disease is neuroendocrine carcinoma.